Biomarker Discovery for Meta-Classification of Melanoma Metastatic Progression Using Transfer Learning

Genes (Basel). 2022 Dec 7;13(12):2303. doi: 10.3390/genes13122303.

Abstract

Melanoma is considered to be the most serious and aggressive type of skin cancer, and metastasis appears to be the most important factor in its prognosis. Herein, we developed a transfer learning-based biomarker discovery model that could aid in the diagnosis and prognosis of this disease. After applying it to the ensemble machine learning model, results revealed that the genes found were consistent with those found using other methodologies previously applied to the same TCGA (The Cancer Genome Atlas) data set. Further novel biomarkers were also found. Our ensemble model achieved an AUC of 0.9861, an accuracy of 91.05, and an F1 score of 90.60 using an independent validation data set. This study was able to identify potential genes for diagnostic classification (C7 and GRIK5) and diagnostic and prognostic biomarkers (S100A7, S100A7, KRT14, KRT17, KRT6B, KRTDAP, SERPINB4, TSHR, PVRL4, WFDC5, IL20RB) in melanoma. The results show the utility of a transfer learning approach for biomarker discovery in melanoma.

Keywords: bias; biomarker; ensemble model; machine learning; melanoma; transfer learning.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / genetics
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Melanoma* / genetics
  • Melanoma* / pathology
  • Prognosis
  • Skin Neoplasms* / genetics

Substances

  • Biomarkers, Tumor

Grants and funding

This research received support from the University of San Agustin and 3R Biosystems.